Berry Street Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-125,000
Closed -$4.22M 139
2021
Q2
$4.22M Buy
+125,000
New +$3.19M 0.37% 38

Berry Street Capital Management's CNST Position: Q3 2021 in Review

Berry Street Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 125,000 shares — an estimated $4.22M sold.

Berry Street Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $4.22M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Berry Street Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Berry Street Capital Management sold 125,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4.22M.
  • Berry Street Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Berry Street Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $4.22M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Berry Street Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.